Anna Chin

440 total citations · 1 hit paper
8 papers, 291 citations indexed

About

Anna Chin is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Surgery. According to data from OpenAlex, Anna Chin has authored 8 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 2 papers in Epidemiology and 1 paper in Surgery. Recurrent topics in Anna Chin's work include Cystic Fibrosis Research Advances (5 papers), Tracheal and airway disorders (3 papers) and Neonatal Respiratory Health Research (2 papers). Anna Chin is often cited by papers focused on Cystic Fibrosis Research Advances (5 papers), Tracheal and airway disorders (3 papers) and Neonatal Respiratory Health Research (2 papers). Anna Chin collaborates with scholars based in United States, Australia and Ireland. Anna Chin's co-authors include Stefan Duensing, Anette Duensing, Tanya G. Weinstock, Neil Ahluwalia, Joshua A. Parry, Linan Wang, Shih–Fan Kuan, Ying Liu, Fengjuan Xuan and Alexander Elbert and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Cancer Research and Virology.

In The Last Decade

Anna Chin

8 papers receiving 289 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2–5 Years with Cystic Fibrosis and at Least One F508del Allele

2023 74 citations Jennifer L. Goralski, Jordana E. Hoppe et al. American Journal of Respiratory and Critical Care Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Chin United States	6	197	48	38	31	31	8	291
Tetsuya Nakazato Japan	11	126 0.6×	31 0.6×	87 2.3×	24 0.8×	14 0.5×	20	317
Yongdong Wu China	10	57 0.3×	74 1.5×	43 1.1×	16 0.5×	62 2.0×	26	267
James Markowitz United States	8	79 0.4×	14 0.3×	15 0.4×	63 2.0×	18 0.6×	13	293
H. Schäfer Germany	9	138 0.7×	29 0.6×	79 2.1×	13 0.4×	28 0.9×	14	308
Fouad Otaki United States	7	166 0.8×	65 1.4×	20 0.5×	23 0.7×	32 1.0×	22	285
Marian Krawczyński Poland	6	47 0.2×	136 2.8×	25 0.7×	25 0.8×	7 0.2×	31	322
C. Lheure France	8	51 0.3×	38 0.8×	111 2.9×	68 2.2×	3 0.1×	17	242
Ludovico Luca Sicignano Italy	10	23 0.1×	113 2.4×	7 0.2×	80 2.6×	14 0.5×	22	307
Lori L. Vanscoy United States	5	332 1.7×	29 0.6×	7 0.2×	18 0.6×	2 0.1×	9	367
A Augarten Israel	6	361 1.8×	95 2.0×	4 0.1×	30 1.0×	4 0.1×	6	444

Countries citing papers authored by Anna Chin

Since Specialization

Citations

This map shows the geographic impact of Anna Chin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Chin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Chin more than expected).

Fields of papers citing papers by Anna Chin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Chin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Chin. The network helps show where Anna Chin may publish in the future.

Co-authorship network of co-authors of Anna Chin

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Chin. A scholar is included among the top collaborators of Anna Chin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Chin. Anna Chin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Durieu, I., Barry Clements, Benedetta Fabrizzi, et al.. (2025). Impact of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Tolerance and Abnormal Glucose Metabolism: A Phase 3b, Open-Label Clinical Trial. American Journal of Respiratory and Critical Care Medicine. 211(10). 1926–1934. 1 indexed citations

2.

Bower, Julie K., Cherry Yin‐Yi Chang, Anna Chin, et al.. (2024). WS01.04 Real-world outcomes in people with cystic fibrosis (pwCF) treated with elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) with up to three years of follow-up. Journal of Cystic Fibrosis. 23. S2–S2. 1 indexed citations

3.

Goralski, Jennifer L., Jordana E. Hoppe, Marcus Mall, et al.. (2023). Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2–5 Years with Cystic Fibrosis and at Least One F508del Allele. American Journal of Respiratory and Critical Care Medicine. 208(1). 59–67. 74 indexed citations breakdown →

4.

Wainwright, Claire, Susanna A. McColley, Paul McNally, et al.. (2023). Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged ≥6 Years with Cystic Fibrosis and at Least One F508del Allele: A Phase 3, Open-Label Clinical Trial. American Journal of Respiratory and Critical Care Medicine. 208(1). 68–78. 34 indexed citations

5.

Bower, Julie K., Nataliya Volkova, Neil Ahluwalia, et al.. (2023). Real-world safety and effectiveness of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis: Interim results of a long-term registry-based study. Journal of Cystic Fibrosis. 22(4). 730–737. 66 indexed citations

6.

Bauer, Sebastian, Joshua A. Parry, Thomas Mühlenberg, et al.. (2009). Proapoptotic Activity of Bortezomib in Gastrointestinal Stromal Tumor Cells. Cancer Research. 70(1). 150–159. 34 indexed citations

7.

Liu, Ying, Joshua A. Parry, Anna Chin, Stefan Duensing, & Anette Duensing. (2008). Soluble histone H2AX is induced by DNA replication stress and sensitizes cells to undergo apoptosis. Molecular Cancer. 7(1). 61–61. 35 indexed citations

8.

Duensing, Anette, Anna Chin, Linan Wang, Shih–Fan Kuan, & Stefan Duensing. (2007). Analysis of centrosome overduplication in correlation to cell division errors in high-risk human papillomavirus (HPV)-associated anal neoplasms. Virology. 372(1). 157–164. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact